2 not yet recruiting, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 2, Completed 1 |
Follow BEBT-908: new trials by email Literature Review of BEBT-908 trials Research Report on BEBT-908
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of BEBT-908 in Combination With Chemotherapy in Patients With Previously Untreated Peripheral T-Cell Lymphoma (PTCL) Ifupinostat Hydrochloride for Injection, Cyclophosphamide for Injection, Doxorubicin Hydrochloride for Injection - Previously Untreated Peripheral T-Cell Lymphoma | Phase 2 | Not yet recruiting | BeBetter Med Inc | 120 | 2026-07-01 | 2026-06-30 |
| BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients BEBT-908, Cyclophosphamide, Vincristine - Acute Lymphoblastic Leukemia | Phase 2 | Not yet recruiting | Ruijin Hospital | 23 | 2025-12-15 | 2025-12-24 |
| Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects BEBT-908 for injection - Relapsed or Refractory Diffuse Large B-cell Lymphoma | Phase 2 | Completed | BeBetter Med Inc | 128 | 2020-06-12 | 2026-08-18 |
Lymphoma, Large B-Cell, Diffuse (1) · Neoplasm, Residual (1) · Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Recurrence (1)
BeBetter Med Inc (2) · Ruijin Hospital (1)
China (3)
Yuankai Shi, Phd (1)